meddevicedb.com FDA Device Reference

OPTISTAR ELITE INJECTION SYSTEM

K073592 Class II Traditional
Decision Date
2008-05-07
Sponsor / Applicant
Mallinckrodt Inc., Liebel-Flarsheim Business

Technical Specification

510(k) Submission ID K073592
Product Code DXT
Medical Specialty / Panel Cardiovascular
Regulation Citation 21 CFR 870.1650
Decision Date 2008-05-07
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

OPTISTAR ELITE INJECTION SYSTEM received FDA 510(k) clearance under submission number K073592, sponsored by Mallinckrodt Inc., Liebel-Flarsheim Business. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2008-05-07.

Classification & Regulation

This clearance is catalogued under FDA product code DXT and 21 CFR 870.1650, within the Cardiovascular review panel as a Class II device.